AdvertisementModerna’s vaccine was also authorized for school-aged children and teens, adding another option alongside Pfizer for those age groups, The Associated Press reported. Moderna applied for FDA approval for its 25-microgram, two-dose regimen in late April. Data from a vaccine study of 6,700 children under the age of 6 showed that its effectiveness against omicron was similar for children and adults, the company said. In addition to vaccinating the youngest Americans, we need to do a better job of vaccinating older children. According to the CDC, just 20% of children ages 5 to 11 have received two doses of the vaccine, while 55% of children 12 to 17 have.

Source: Huffington Post June 17, 2022 19:44 UTC